Soligenix
SNGX
#10619
Rank
A$4.93 M
Marketcap
A$0.48
Share price
0.00%
Change (1 day)
-83.93%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$12.97 Million a decrease over its 2023 earnings that were of -A$10.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million49.44%
2024 -A$12.97 Million22.96%
2023 -A$10.55 Million-45.74%
2022 -A$19.44 Million11.88%
2021 -A$17.38 Million-32.37%
2020 -A$25.69 Million83.18%
2019 -A$14.03 Million11.57%
2018 -A$12.57 Million19.29%
2017 -A$10.54 Million33%
2016 -A$7.93 Million-19.7%
2015 -A$9.87 Million5.16%
2014 -A$9.39 Million
2010 -A$10.59 Million26.12%
2009 -A$8.4 Million75.1%
2008 -A$4.8 Million-45.38%
2007 -A$8.78 Million-22.84%
2006 -A$11.38 Million66.15%
2005 -A$6.85 Million-16.65%
2004 -A$8.22 Million13.28%
2003 -A$7.26 Million-11.88%
2002 -A$8.23 Million-59.44%
2001 -A$20.29 Million378.18%
2000 -A$4.25 Million-38.53%
1999 -A$6.91 Million-18.43%
1998 -A$8.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B-271,360.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.13 B-82,500.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.68 B-62,347.25%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.19 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$57.94 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.98 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.82 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.22 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA